Cancer Drugs Fund condemned as expensive and ineffective

Treatments approved by David Cameron’s scheme were not worth money, extended life very little and often had adverse side-effects, study finds
The Cancer Drugs Fund, set up by the government to pay for expensive medicines that the NHS would not normally finance, failed to benefit patients and may have resulted in some of them suffering unnecessarily from toxic side-effects, experts say.
An analysis in a leading cancer journal has found that the fund paid out £1.27bn from 2010 to 2016 – an amount that would have paid for an entire year of mainstream cancer drugs for the NHS.
Read more: Cancer Drugs Fund condemned as expensive and ineffective